Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

The Gut Microbiome Profile in Obesity, A Systematic Review

  • Castañer, Olga|||0000-0003-3169-997X
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Park, Yong-Moon
  • Lee, Seung-Hwan|||0000-0002-3964-3877
  • Magkos, Faidon
  • Shiow, Sue-Anne Toh Ee
  • Schröder, Helmut|||0000-0003-2231-5081
Gut microbiome has been identified in the past decade as an important factor involved in obesity, but the magnitude of its contribution to obesity and its related comorbidities is still uncertain. Among the vast quantity of factors attributed to obesity, environmental, dietary, lifestyle, genetic, and others, the microbiome has aroused curiosity, and the scientific community has published many original articles. Most of the studies related to microbiome and obesity have been reported based on the associations between microbiota and obesity, and the in-depth study of the mechanisms related has been studied mainly in rodents and exceptionally in humans. Due to the quantity and diverse information published, the need of reviews is mandatory to recapitulate the relevant achievements. In this systematic review, we provide an overview of the current evidence on the association between intestinal microbiota and obesity. Additionally, we analyze the effects of an extreme weight loss intervention such as bariatric surgery on gut microbiota. The review is divided into 2 sections: first, the association of obesity and related metabolic disorders with different gut microbiome profiles, including metagenomics studies, and second, changes on gut microbiome after an extreme weight loss intervention such as bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Short- and medium-term impact of bariatric surgery on the activities of CYP2D6, CYP3A4, CYP2C9, and CYP1A2 in morbid obesity

  • Rodríguez-Morató, Jose|||0000-0002-8133-9983
  • Goday Arnó, Albert|||0000-0001-7356-1595
  • Langohr, Klaus|||0000-0001-7075-9192
  • Pujadas, Mitona|||0000-0002-0506-3030
  • Civit, Ester
  • Pérez-Mañá, Clara|||0000-0001-6343-6918
  • Papaseit, Esther|||0000-0003-2620-4274
  • Ramon, Jose Manuel
  • Benaiges, David|||0000-0001-5411-364X
  • Castañer, Olga|||0000-0003-3169-997X
  • Farré Albaladejo, Magí|||0000-0001-8338-7543
  • Torre, Rafael de la|||0000-0002-6765-1866
Morbid obesity and bariatric surgery induce anatomical, physiological and metabolic alterations that may alter the body's disposition of drugs. Current literature on this topic is limited and sometimes inconsistent. Cytochrome P450 (CYP) is a superfamily of enzymes that metabolize around 75% of all marketed drugs. The purpose of this study was to evaluate the impact of body mass index and bariatric surgery on CYP activities. Firstly, we evaluated the in vivo activity of 4 major CYP isoenzymes (CYP2D6, CYP3A4, CYP2C9, and CYP1A2) in normal weight, overweight, and morbidly obese individuals. Secondly, we assessed the short- (1 month) and medium-term (6 month) effects of the most commonly employed bariatric surgery techniques (laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass) on the activity of these enzymes. CYP3A4 activity was lower in morbidly obese individuals, compared to normal-weight controls. Interestingly, bariatric surgery normalized CYP3A4 activity. In comparison with normal-weight controls, morbidly obese individuals had higher CYP2D6 activity, which was only observed in individuals with two functional alleles for this isoenzyme. Neither body mass index nor surgery had significant effects on CYP2C9 and CYP1A2 activities. Overall, no relevant differences in CYP activities were found between surgical techniques. In conclusion, further studies should evaluate whether the observed alterations in CYP3A4 activity will require dose adjustments for CYP3A4 substrates especially in morbidly obese individuals before and after bariatric surgery.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Isotemporal substitution of inactive time with physical activity and time in bed, cross-sectional associations with cardiometabolic health in the PREDIMED-Plus study

  • Galmes-Panades, Aina M.|||0000-0001-6977-9874
  • Varela-Mato, Veronica
  • Konieczna, Jadwiga|||0000-0002-2947-1338
  • Wärnberg, Julia|||0000-0002-8408-316X
  • Martínez González, Miguel Ángel|||0000-0002-3917-9808
  • Salas-Salvadó, Jordi|||0000-0003-2700-7459
  • Corella, Dolores|||0000-0002-2366-4104
  • Schröder, Helmut|||0000-0003-2231-5081
  • Vioque, Jesús|||0000-0002-2284-148X
  • Alonso-Gómez, Ángel María|||0000-0003-2945-7509
  • Martínez, J. Alfredo|||0000-0001-5218-6941
  • Serra-Majem, Luís|||0000-0002-9658-9061
  • Estruch, Ramón|||0000-0003-1260-4445
  • Tinahones, Francisco J.|||0000-0001-6871-4403
  • Lapetra, José|||0000-0002-3873-5737
  • Pintó, Xavier|||0000-0002-2216-2444
  • Tur, Josep Antonio|||0000-0002-6940-0761
  • García-Rios, Antonio|||0000-0001-7320-9006
  • Riquelme-Gallego, Blanca|||0000-0003-3422-7310
  • Gaforio, José J.|||0000-0003-2996-9301
  • Matía-Martín, Pilar|||0000-0001-9844-3755
  • Daimiel, Lidia|||0000-0001-9898-6629
  • Micó Pérez, Rafael Manuel|||0000-0002-2575-1236
  • Vidal, Josep|||0000-0002-4564-4518
  • Vázquez, Clotilde
  • Ros, Emilio|||0000-0002-2573-1294
  • Garcia-Arellano, Ana
  • Díaz-López, Andrés|||0000-0002-7500-5629
  • Asensio, Eva Maria|||0000-0003-4558-0988
  • Castañer, Olga|||0000-0003-3169-997X
  • Fiol, Francisca
  • Mira-Castejón, Luis Alfredo
  • Moreno Rodríguez, Anai
  • Benavente-Marín, Juan Carlos
  • Abete, Itziar|||0000-0002-6475-5387
  • Tomaino, Laura
  • Casas, Rosa|||0000-0002-0211-9166
  • Barón López, Francisco Javier|||0000-0001-8707-304X
  • Fernández-García, José C.|||0000-0003-2229-8488
  • Santos-Lozano, José Manuel
  • Galera, Ana
  • Mascaró, Catalina M.
  • Razquín, Cristina|||0000-0003-3480-2645
  • Papandreou, Christopher|||0000-0002-6803-507X
  • Portoles, Olga
  • Pérez-Vega, Karla Alejandra|||0000-0002-7524-2034
  • Fiol-Sala, Miquel
  • Compañ Gabucio, Laura M.|||0000-0001-5324-1535
  • Vaquero-Luna, Jessica
  • Ruiz-Canela, Miguel|||0000-0002-7684-2787
  • Becerra-Tomás, Nerea|||0000-0002-4429-6507
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Romaguera, Dora|||0000-0002-5762-8558
This study explored the association between inactive time and measures of adiposity, clinical parameters, obesity, type 2 diabetes and metabolic syndrome components. It further examined the impact of reallocating inactive time to time in bed, light physical activity (LPA) or moderate-to-vigorous physical activity (MVPA) on cardio-metabolic risk factors, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. This is a cross-sectional analysis of baseline data from 2189 Caucasian men and women (age 55-75 years, BMI 27-40 Kg/m 2) from the PREDIMED-Plus study (). All participants had ≥3 components of the metabolic syndrome. Inactive time, physical activity and time in bed were objectively determined using triaxial accelerometers GENEActiv during 7 days (ActivInsights Ltd., Kimbolton, United Kingdom). Multiple adjusted linear and logistic regression models were used. Isotemporal substitution regression modelling was performed to assess the relationship of replacing the amount of time spent in one activity for another, on each outcome, including measures of adiposity and body composition, biochemical parameters and blood pressure in older adults. Inactive time was associated with indicators of obesity and the metabolic syndrome. Reallocating 30 min per day of inactive time to 30 min per day of time in bed was associated with lower BMI, waist circumference and glycated hemoglobin (HbA1c) (all p -values < 0.05). Reallocating 30 min per day of inactive time with 30 min per day of LPA or MVPA was associated with lower BMI, waist circumference, total fat, visceral adipose tissue, HbA1c, glucose, triglycerides, and higher body muscle mass and HDL cholesterol (all p-values < 0.05). Inactive time was associated with a poor cardio-metabolic profile. Isotemporal substitution of inactive time with MVPA and LPA or time in bed could have beneficial impact on cardio-metabolic health.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Virgin Olive Oil Phenolic Compounds Modulate the HDL Lipidome in Hypercholesterolaemic Subjects, A Lipidomic Analysis of the VOHF Study

  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Catalán, Úrsula
  • Valls, Rosa Maria|||0000-0002-3351-0942
  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Rubió, Laura
  • Castañer, Olga|||0000-0003-3169-997X
  • Macià, Alba
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Motilva, Maria José
  • Covas Planells, Maria Isabel
  • Giera, Martin
  • Remaley, Alan T.
  • Solà, Rosa|||0000-0002-8359-235X
Scope: The lipidomic analysis of high-density lipoprotein (HDL) could be useful to identify new biomarkers of HDL function. Methods and results: A randomized, controlled, double-blind, crossover trial (33 hypercholesterolaemic subjects) is performed with a control virgin olive oil (VOO), VOO enriched with its own phenolic compounds (FVOO), or VOO enriched with additional phenolic compounds from thyme (FVOOT) for 3 weeks. HDL lipidomic analyses are performed using the Lipidyzer platform. VOO and FVOO intake increase monounsaturated-fatty acids (FAs) and decrease saturated and polyunsaturated FAs in triacylglyceride (TAG) species, among others species. In contrast, FVOOT intake does not induce these FAs changes. The decrease in TAG52:3(FA16:0) after VOO intake and the decrease in TAG52:5(FA18:2) after FVOO intake are inversely associated with changes in HDL resistance to oxidation. After FVOO intake, the decrease in TAG54:6(FA18:2) in HDL is inversely associated with changes in HDL cholesterol efflux capacity. Conclusion: VOO and FVOO consumption has an impact on the HDL lipidome, in particular TAG species. Although TAGs are minor components of HDL mass, the observed changes in TAG modulated HDL functionality towards a cardioprotective mode. The assessment of the HDL lipidome is a valuable approach to identify and characterize new biomarkers of HDL function.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

A functional virgin olive oil enriched with olive oil and thyme phenolic compounds improves the expression of cholesterol efflux-related genes, A randomized, crossover, controlled trial

  • Farràs Mañé, Marta|||0000-0001-9776-3773
  • Arranz, Sara|||0000-0003-2397-5145
  • Carrión, Silvia|||0000-0002-1354-2488
  • Subirana, Isaac|||0000-0003-1676-0197
  • Muñoz Aguayo, Daniel|||0000-0001-8173-0168
  • Blanchart, Gemma|||0000-0003-1965-8235
  • Kool, Marjon
  • Solà, Rosa|||0000-0002-8359-235X
  • Motilva, María José
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Rubió, Laura
  • Fernández-Castillejo, Sara|||0000-0002-8109-9713
  • Pedret, Anna
  • Estruch, Ramón|||0000-0003-1260-4445
  • Covas Planells, Maria Isabel
  • Fitó, Montserrat|||0000-0002-1817-483X
  • Hernáez, Álvaro|||0000-0001-8593-1477
  • Castañer, Olga|||0000-0003-3169-997X
The consumption of antioxidant-rich foods such as virgin olive oil (VOO) promotes high-density lipoprotein (HDL) anti-atherogenic capacities. Intake of functional VOOs (enriched with olive/thyme phenolic compounds (PCs)) also improves HDL functions, but the gene expression changes behind these benefits are not fully understood. Our aim was to determine whether these functional VOOs could enhance the expression of cholesterol efflux-related genes. In a randomized, double-blind, crossover, controlled trial, 22 hypercholesterolemic subjects ingested for three weeks 25 mL/day of: (1) a functional VOO enriched with olive oil PCs (500 mg/kg); (2) a functional VOO enriched with olive oil (250 mg/kg) and thyme PCs (250 mg/kg; FVOOT), and; (3) a natural VOO (olive oil PCs: 80 mg/kg, control intervention). We assessed whether these interventions improved the expression of cholesterol efflux-related genes in peripheral blood mononuclear cells by quantitative reverse-transcription polymerase chain reactions. The FVOOT intervention upregulated the expression of CYP27A1 (P = 0.041 and P = 0.053, versus baseline and the control intervention, respectively), CAV1 (P = 0.070, versus the control intervention), and LXRβ, RXRα, and PPARβ/δ (P = 0.005, P = 0.005, and P = 0.038, respectively, relative to the baseline). The consumption of a functional VOO enriched with olive oil and thyme PCs enhanced the expression of key cholesterol efflux regulators, such as CYP27A1 and nuclear receptor-related genes.